Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Anna Lisa Magnante"'
1
Akademický článek
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
Autor: Francesca De Felice, Ilaria Benevento, Anna Lisa Magnante, Daniela Musio, Nadia Bulzonetti, Rossella Caiazzo, Vincenzo Tombolini
Publikováno v: BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background Neoadjuvant fluoropirimidine (5FU)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition of oxaliplatin (OXP) will further improve clinical outcomes is s
Externí odkaz: https://doaj.org/article/944615dae7b344a99fecb1d6c83c1405
Zobrazit plný text záznamu
2
Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery
Autor: Francesca De Felice, Daniela Musio, Nadia Bulzonetti, Rossella Caiazzo, Vincenzo Tombolini, Anna Lisa Magnante, Dario De Falco, Lavinia Grapulin
Publikováno v: International Journal of Dermatology. 61:911-915
INTRODUCTION: The optimal definitive radiotherapy (RT) scheme in cutaneous squamous cell carcinoma (cSCC) remains controversial, especially in elderly patients. METHODS: Data of elderly patients with cSCC lesion(s) treated with weekly hypofractionate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4e27fbb42f451acd49f46b28936edc
https://doi.org/10.1111/ijd.16008
Zobrazit plný text záznamu
4
Clinical predictive factors of pathologic complete response in locally advanced rectal cancer
Autor: Pietro Lucchetti, F Pugliese, Luciano Izzo, Pierfrancesco Di Cello, Sara Izzo, Vincenzo Tombolini, Daniela Musio, Paolo Izzo, Nadia Bulzonetti, Anna Lisa Magnante, Francesca De Felice
Publikováno v: Oncotarget
// Francesca De Felice 1 , Luciano Izzo 2 , Daniela Musio 1 , Anna Lisa Magnante 1 , Nadia Bulzonetti 1 , Federico Pugliese 2 , Paolo Izzo 2 , Pierfrancesco Di Cello 2 , Pietro Lucchetti 2 , Sara Izzo 2 , Vincenzo Tombolini 1, 3 1 Department of Radio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d2d625e5b791c90c0daf02421402080
http://europepmc.org/articles/PMC5078102
Zobrazit plný text záznamu
5
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
Autor: Rossella Caiazzo, Nadia Bulzonetti, Daniela Musio, Vincenzo Tombolini, Francesca De Felice, Anna Lisa Magnante, Ilaria Benevento
Publikováno v: BMC Cancer
Background Neoadjuvant fluoropirimidine (5FU)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition of oxaliplatin (OXP) will further improve clinical outcomes is still deba
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904d74e0b28a3fe3e04430b35b66024a
https://doi.org/10.1186/s12885-017-3323-4
Zobrazit plný text záznamu
6
Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Autor: Marco Rengo, Anna Lisa Magnante, F. De Felice, C. N. De Cecco, Andrea Laghi, Daniela Musio, Maria Ciolina, Vincenzo Tombolini
Purpose To analyze diffusion-weighted magnetic resonance imaging (DW-MRI) for treatment response assessment in locally advanced rectal cancer (LARC). Patients and methods Patients with histologically proven rectal adenocarcinoma, stage II–III disea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b279220ec6c688a4cc88852e3dcd990
http://hdl.handle.net/11573/952036
Zobrazit plný text záznamu
7
Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience
Autor: Ilaria Benevento, Rossella Caiazzo, Francesca De Felice, Anna Lisa Magnante, Daniela Musio, Vincenzo Tombolini, Nadia Bulzonetti
Publikováno v: Clinical colorectal cancer. 15(2)
Purpose To report the long-term follow-up data and determine the toxicity rate concerning patients with locally advanced rectal cancer (LARC) treated with an intensified neoadjuvant treatment regimen. Patients and Methods Patients with histologically
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427d4ba85a8340eaee9b6676aa23f203
https://pubmed.ncbi.nlm.nih.gov/26952656
Zobrazit plný text záznamu
8
Diffusion-Weighted Magnetic Resonance Application in Response Prediction before, during, and after Neoadjuvant Radiochemotherapy in Primary Rectal Cancer Carcinoma
Autor: Daniela Musio, Maria Ciolina, Vincenzo Tombolini, Nicola Raffetto, Adriano Redler, Andrea Laghi, Francesca De Felice, Anna Lisa Magnante, Carlo N. De Cecco, Marco Rengo
Publikováno v: BioMed Research International
BioMed Research International, Vol 2013 (2013)
Introduction. Our interest was to monitor treatment response using ADC value to predict response of rectal tumour to preoperative radiochemotherapy.Materials and Methods. Twenty-two patients were treated with long course of radiochemotherapy, followe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61fae6a5d1bc2dfed5d7e3e2af10cf9
http://europepmc.org/articles/PMC3722900
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje